Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Change in Accured Expenses: 2018-2024

Historic Change in Accured Expenses for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to -$8.5 million.

  • Therapeutics' Change in Accured Expenses rose 4452.11% to $3.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$8.5 million, marking a year-over-year decrease of 215.32%. This contributed to the annual value of -$8.5 million for FY2024, which is 215.32% down from last year.
  • Per Therapeutics' latest filing, its Change in Accured Expenses stood at -$8.5 million for FY2024, which was down 215.32% from $7.3 million recorded in FY2023.
  • In the past 5 years, Therapeutics' Change in Accured Expenses ranged from a high of $7.3 million in FY2023 and a low of -$8.5 million during FY2024.
  • In the last 3 years, Therapeutics' Change in Accured Expenses had a median value of $3.7 million in 2022 and averaged $862,000.
  • In the last 5 years, Therapeutics' Change in Accured Expenses skyrocketed by 297.64% in 2022 and then plummeted by 215.32% in 2024.
  • Therapeutics' Change in Accured Expenses (Yearly) stood at $2.4 million in 2020, then plummeted by 60.96% to $933,000 in 2021, then skyrocketed by 297.64% to $3.7 million in 2022, then surged by 97.71% to $7.3 million in 2023, then crashed by 215.32% to -$8.5 million in 2024.